FOMX - Foamix Pharmaceuticals Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5145.32M
Enterprise Value 364.98M
Trailing P/E N/A
Forward P/E 1-1.91
PEG Ratio (5 yr expected) 10.01
Price/Sales (ttm)48.49
Price/Book (mrq)1.86
Enterprise Value/Revenue 321.68
Enterprise Value/EBITDA 6-1.00

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,170.70%

Management Effectiveness

Return on Assets (ttm)-55.69%
Return on Equity (ttm)-103.63%

Income Statement

Revenue (ttm)3M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-66.00%
Gross Profit (ttm)3.6M
EBITDA -64.75M
Net Income Avi to Common (ttm)-63.39M
Diluted EPS (ttm)-1.3240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.27M
Total Cash Per Share (mrq)1.51
Total Debt (mrq)1.94M
Total Debt/Equity (mrq)2.48
Current Ratio (mrq)9.03
Book Value Per Share (mrq)1.43

Cash Flow Statement

Operating Cash Flow (ttm)-62.11M
Levered Free Cash Flow (ttm)-39.83M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.28
52-Week Change 3-49.72%
S&P500 52-Week Change 35.44%
52 Week High 37.6000
52 Week Low 32.3000
50-Day Moving Average 32.7237
200-Day Moving Average 33.4658

Share Statistics

Avg Vol (3 month) 3280.47k
Avg Vol (10 day) 3375.87k
Shares Outstanding 554.43M
Float 38.88M
% Held by Insiders 10.70%
% Held by Institutions 1291.23%
Shares Short (May 31, 2019) 41.64M
Short Ratio (May 31, 2019) 45.44
Short % of Float (May 31, 2019) 43.03%
Short % of Shares Outstanding (May 31, 2019) 43.01%
Shares Short (prior month Apr 30, 2019) 41.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A